You are here

Yeda Research and Development

Dr. Bruce Lefker: Bridging the gap between basic science and drug discovery
23.02.2017

Dr. Bruce Lefker is currently working in the G-INCPM for one year as part of a five-year collaboration between the Weizmann Institute, Yeda...

YEDA
16.03.2016

Portrazza is approved to by the US FDA to treat lung cancer

Amir Naiberg, Prof. Mudi Sheves, Stefan Oschmann and Belén Garijo
16.02.2016

Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, by signing a...

Prof. Daniel Zajfman presents award to Karl-Ludwig Kley
16.02.2016

The Weizmann Institute conferred the renowned Weizmann Award in the Sciences and Humanities to Karl-Ludwig Kley, CEO and Chairman of the Executive...